Saving Time and Money with Alicyclobacillus Rapid Microbiology Method
Alicyclobacillus contamination, while not harmful to consumer health, can lead to product spoilage and significant brand image issues, resulting in costly recalls and storage problems. The MICA Advance® technology offers rapid, accurate detection to help you stay ahead.
Speakers
Alexandre Muller
Innovation Manager | Diamidex
Mario Chronis
General Manager | Aspis Hellenic Juice SA
Key Learning Objectives
- The impact of Alicyclobacillus on product quality and the common challenges in its detection
- The easiest rapid method to reduce testing times, helping labs release products faster
- Strategies to optimize lab workflows: reducing manpower and consumables
- A real-world case study of successful problem-solving
- Live Q&A on your specific concerns and challenges
About Diamidex
Diamidex develops and markets fast culture-based solutions with automatic enumeration and reporting for laboratories across a variety of industries, delivering earlier results that are more replicable, cost-efficient and equivalent to the gold standard, with a lower carbon footprint.
Watch Now: Saving Time and Money with Alicyclobacillus Rapid Microbiology Method
This webinar is available on demand. Fill in the form to watch the full recording — we'll email you the link too.
- December 11, 2024 · 45 minutes
- Alexandre Muller, Diamidex
- kbiinfo@krishgen.com
- +91 22 49198700
Your details
Request the recording
Fill in your details and you'll go straight to the recording — we'll also email you the link.
More Webinars
Shortcuts to Discovery and Characterization of Monoclonal Antibodies
Monoclonal antibody (mAb) discovery and characterization often face significant delays due to iterative screening cycles, late-stage functional failures, and downstream analytical bottlenecks. This webinar details five practical shortcuts that accelerate timelines from target validation to preclinical characterization.
View Webinar June 12, 2026Viral Vectors & CRISPR for Building Disease Models
Gene editing and viral vector technologies are transforming the development of advanced disease models for translational research.
View Webinar April 17, 2026Advanced Immunocompetent Primary Human Airway Models for Respiratory Disease Modeling
Advancements in human-relevant in vitro models are transforming how respiratory diseases are studied and how drug safety and efficacy are evaluated.
View Webinar